FY2025 · ended Dec 31, 2025 · Revenue $911.98M, +13.6% YoY · Filed Feb 13, 2026
Inspire Medical Systems, Inc. (INSP) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $912.0 million and net income of $145.4 million. Free cash flow was $78.5 million. As of Sep 30, 2026 it held $453.1 million in cash and investments and $28.6 million in total debt.
Revenue (TTM)
$880.94M
-0.2% vs year-ago TTM
Net income (TTM)
$100.72M
+126.0% vs year-ago TTM
Operating cash flow (TTM)
$134.97M
+1.0% vs year-ago TTM
Free cash flow (TTM)
$97.89M
-0.9% vs year-ago TTM
EPS (TTM)
$3.48
+135.0% vs year-ago TTM
Dividend per share
None
Shares outstanding
28.59M
-3.6% vs prior year
Net cash
$424.49M
as of Sep 30, 2026
Operating margin
1.8%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INSP (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Golden Valley, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1609550
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M | -$39.9M |
| Net income | $145.4M | $53.5M | -$21.2M | -$44.9M | -$42.0M |
| Diluted EPS | $4.89 | $1.75 | -$0.72 | -$1.60 | -$1.54 |
| Operating cash flow | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M |
| Free cash flow | $78.5M | $91.1M | $1.0M | $2.5M | -$24.8M |
| Total assets | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M |
| Total liabilities | $126.2M | $118.7M | $104.3M | $68.9M | $66.0M |
| Stockholders' equity | $781.2M | $689.7M | $572.5M | $496.0M | $229.0M |
| Cash and investments | $404.6M | $516.5M | $469.5M | $451.4M | $224.4M |
| Total debt | $32.2M | $31.8M | $24.8M | $8.9M | $33.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
All 897 Inspire Medical Systems, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.